查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1677075

合成生物学平台市场：按产品、应用和最终用户划分 - 2025-2030 年全球预测

Synthetic Biology Platforms Market by Offering, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

合成生物学平台市场预计将从 2024 年的 41.1 亿美元成长到 2025 年的 50.4 亿美元，复合年增长率为 22.81%，到 2030 年达到 141 亿美元。

主要市场统计数据
基准年 2024 年 41.1亿美元
预计 2025 年 50.4 亿美元
预测年份 2030 141亿美元
复合年增长率（%） 22.81％

合成生物学平台是生物技术研究和工业应用的突破性前沿。近年来，生物学和工程学的融合改变了我们对基因工程的认识，并为合成、修改和利用生物系统提供了前所未有的机会。本报告探讨了快速发展的合成生物学领域，重点在于精确度、扩充性和系统创新。

新兴趋势凸显了此类平台在应对疾病治疗、个人化治疗和永续工业流程等复杂挑战方面将发挥的关键作用。研究人员和产业专家正在不懈地努力，不断突破可能的界限，重新构想从救命药品到先进农业投入品等产品的设计和生产方式。

随着学术研究与商业发展之间的互动不断加强，相关人员正在见证技术能力的重大转变。先进的资料分析和高通量筛检方法的整合为高效的产品开发和简化的业务工作流程开闢了新的可能性。本报告深入探讨了推动这一革命性领域发展的关键因素，为决策者和行业专业人士提供了重要的见解。

塑造合成生物学创新的变革

近年来，合成生物学周围的环境发生了重大变化。加速的技术进步重新定义了研究方法，使得操纵和编程生物系统变得更加容易。研究人员目前正在利用复杂的基因编辑技术和自动化平台实现从传统方法到高精度合成生物学应用的无缝过渡。

对生物技术基础设施的大量投资使得原型製作更快且扩充性。这种演变不仅是渐进的，而且代表着模式转移，它将支持新的经营模式并加快创新步伐。透过强调数位技术、工程和生物学等各个领域的跨学科合作，该行业的成长轨迹得到了进一步丰富。

与以往任何时候相比，企业现在都能够实施将人工智慧与生物学洞察相结合的综合方法，从而发现新的治疗目标并开发创新的商业产品。这些发展激发了公共和私营部门的兴趣，创造了一个由协作研究、开放原始码平台和敏捷法规结构驱动的生态系统，确保了安全和快速进入市场。

针对目标市场机会的关键细分洞察

仔细检视市场就会发现，差异化的部分凸显了合成生物学平台的多功能性。这些包括 DNA 定序、DNA 合成和 mRNA 合成，每种技术对客製化基因工程和诊断准确性都有其独特的贡献。同样重要的是基于应用的细分，其中创新正在推动诸如抗体发现与次世代定序（NGS）相结合、细胞和基因治疗的突破以及不断发展的疫苗开发领域等领域的进步，所有这些都需要专门的方法和尖端技术。

此外，基于最终用户的细分为跨不同垂直行业部署这些平台提供了丰富的见解。农业等市场正受益于基改作物和产量的提高，而食品和饮料产业正在利用生物创新来提高其产品的安全性和营养成分。同时，製药和生命科学产业正在利用合成生物学来彻底改变药物发现和开发通讯协定。

这些细分领域不仅代表了合成生物学市场的广泛商机，也反映了相关人员的多样化应用和策略重点。理解这些细微差别对于协调研究和商业投资策略以充分发挥这个变革性产业的潜力至关重要。

目录

第 1 章 简介

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 个人化医疗和客製化医疗保健解决方案日益流行
      • 扩展生物资讯学和计算工具以支援合成路线设计
    • 限制因素
      • 研发成本高，相容性问题
    • 机会
      • 全球医疗保健和农业领域对有效解决方案的需求推动了合成生物学的发展
      • 利用合成生物学开发传统塑胶的生物分解性替代品
    • 任务
      • 合成生物学创新中应对网路安全威胁和确保资料完整性的挑战
  • 市场区隔分析
    • 我们提供的：mRNA 疫苗革命推动了 mRNA 合成的进化
    • 最终用户：扩大合成生物学平台在製药和生命科学产业的应用
  • 波特五力分析
  • PESTEL 分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

6. 合成生物学平台市场（依产品分类）

  • DNA序列分析
  • DNA 合成
  • mRNA合成

7. 合成生物学平台市场（依应用）

  • 抗体发现和NGS
  • 细胞和基因治疗
  • 疫苗研发

8. 合成生物学平台市场（依最终用户划分）

  • 农业产业
  • 食品饮料业
  • 製药和生命科学

9. 美洲合成生物平台市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

10. 亚太地区合成生物平台市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

11. 欧洲、中东和非洲合成生物学平台市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章 竞争格局

  • 2024 年市场占有率分析
  • FPNV 定位矩阵，2024 年
  • 竞争情境分析
  • 战略分析与建议

公司列表

  • Agilent Technologies, Inc.
  • American Institute of Chemical Engineers
  • Amyris, Inc.
  • Antheia, Inc.
  • Arbor Biosciences
  • Codexis, Inc.
  • CSIRO
  • DNA Script
  • ElevateBio, LLC
  • Engineering Biology Research Center
  • Genetic Engineering & Biotechnology
  • Genomatica, Inc.
  • Genome Canada
  • Ginkgo Bioworks, Inc.
  • Gniubiotics
  • Harvard Medical School
  • Illumina Inc
  • Integrated DNA Technologies, Inc.
  • LanzaTech
  • Mammoth Biosciences, Inc.
  • New England Biolabs
  • Sojitz Corporation
  • Synbio Technologies
  • Twist Bioscience Corporation
  • Zymergen Inc.
Product Code: MRR-14332CB034A4

The Synthetic Biology Platforms Market was valued at USD 4.11 billion in 2024 and is projected to grow to USD 5.04 billion in 2025, with a CAGR of 22.81%, reaching USD 14.10 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 4.11 billion
Estimated Year [2025] USD 5.04 billion
Forecast Year [2030] USD 14.10 billion
CAGR (%) 22.81%

Synthetic biology platforms represent a groundbreaking frontier in biotechnological research and industrial application. In recent times, the fusion of biology and engineering has revolutionized our understanding of genetic manipulation, offering unprecedented opportunities to synthesize, modify, and harness biological systems. This report examines the rapidly evolving field of synthetic biology, characterized by its emphasis on precision, scalability, and systemic innovation.

Emerging trends have highlighted the critical role of these platforms in addressing complex challenges such as disease treatment, customized therapeutics, and sustainable industrial processes. Researchers and industry experts are tirelessly working to push the boundaries of what is possible, reshaping how products ranging from life-saving drugs to advanced agricultural inputs are designed and produced.

As the interplay between academic research and commercial development intensifies, stakeholders are witnessing a significant transformation in technological capabilities. The integration of advanced data analytics and high-throughput screening methods has unlocked new potential for efficient product development and streamlined operational workflows. This report offers an in-depth exploration of the key elements powering this revolutionary sector, providing essential insights for decision-makers and industry experts alike.

Transformative Shifts Reshaping Synthetic Biology Innovation

The synthetic biology landscape has undergone profound changes over the past few years. Accelerated technological advancements have redefined research methodologies, making it easier to manipulate and program biological systems. Researchers now leverage sophisticated genetic editing techniques and automated platforms, allowing for a seamless transition from traditional methods to high-precision synthetic biology applications.

Significant investments in biotechnology infrastructure have enabled faster prototyping and improved scalability. This evolution is not merely incremental but represents a paradigm shift that underpins new business models and accelerates the rate of innovation. Emphasis on interdisciplinary collaboration across sectors, including digital technology, engineering, and biology, has further enriched the growth trajectory of this industry.

Companies are now more capable than ever of undertaking integrated approaches that combine artificial intelligence with biological insights, leading to the discovery of novel therapeutic targets and innovative commercial products. These developments have spurred a surge in both public and private sector interest, culminating in an ecosystem driven by collaborative research, open-source platforms, and agile regulatory frameworks that ensure both safety and rapid market entry.

Key Segmentation Insights for Targeting Market Opportunities

A careful examination of the market reveals differentiated segments that highlight the multifunctional nature of synthetic biology platforms. One clear dimension stems from the offerings available, which include areas such as DNA Sequencing, DNA Synthesis, and mRNA Synthesis, each contributing uniquely to customized gene manipulation and diagnostic precision. Equally important is the segmentation based on application where innovations drive advancements across Antibody Discovery combined with next-generation sequencing (NGS), Cell and Gene Therapy breakthroughs, and the evolving domain of Vaccine Development, all of which demand specialized approaches and leading-edge technologies.

In addition, the segmentation based on end users offers rich insights into the deployment of these platforms across diverse industries. Markets such as the Agriculture Industry benefit from engineered crops and improved yields, whereas the Food & Beverage Industry leverages biological innovations to enhance product safety and nutritional content. The Pharmaceutical & Life Science Industry, meanwhile, uses synthetic biology to revolutionize drug discovery and development protocols.

Together, these segments not only illustrate the range of opportunities within the synthetic biology market but also reflect the diverse applications and strategic priorities of stakeholders. Understanding these nuances is essential for aligning both research and commercial investment strategies to harness the full potential of this transformative industry.

Based on Offering, market is studied across DNA Sequencing, DNA Synthesis, and mRNA Synthesis.

Based on Application, market is studied across Antibody Discovery & NGS, Cell & Gene Therapy, and Vaccine Development.

Based on End User, market is studied across Agriculture Industry, Food & Beverage Industry, and Pharmaceutical & Life Science Industry.

Regional Insights Driving Global Synthetic Biology Dynamics

The synthetic biology market exhibits significant regional variation driven by local innovation ecosystems and policy frameworks. In the Americas, robust funding mechanisms and close collaboration between academic institutions and industry have propelled breakthroughs in genetic engineering and bio-manufacturing. The region offers a fertile ground for rapid product development, supported by a strong intellectual property environment and a well-established biotech industry.

Across Europe, the Middle East and Africa, regulatory harmonization and strategic public investments have fostered a conducive environment for pioneering research in synthetic biology. This region is characterized by an emphasis on sustainability and green technologies, which has encouraged the integration of synthetic biology in environmental management and resource optimization strategies.

The Asia-Pacific region has emerged as a dynamic hub with a burgeoning biotechnology sector, supported by governmental incentives and substantial investments in research infrastructure. Rapid industrialization, coupled with a growing focus on health and agriculture, has spurred innovative applications that promise significant economic and social impact. Each of these regions offers unique strengths that contribute to the global tapestry of synthetic biology advancements.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Leading Companies Shaping the Synthetic Biology Ecosystem

The market is witnessing the formidable influence of a diverse array of companies that are setting benchmarks in technology, research, and commercial innovation. Key players include Agilent Technologies, Inc. and American Institute of Chemical Engineers, which bring decades of expertise and innovation to the domain. Firms like Amyris, Inc. and Antheia, Inc. are known for their pioneering work in metabolic engineering and novel biochemical production.

Organizations such as Arbor Biosciences and Codexis, Inc. have emphasized the importance of customized solutions in genetic editing and synthetic enzyme development, while CSIRO and DNA Script provide cutting-edge tools that consistently push the boundaries of gene synthesis. ElevateBio, LLC and Engineering Biology Research Center contribute significantly to streamlined research and translational applications.

Additional organizations including Genetic Engineering & Biotechnology and Genomatica, Inc. stand out for their forward-thinking approaches to sustainable production. Research institutions like Genome Canada and Harvard Medical School support essential academic advancements, and companies such as Ginkgo Bioworks, Inc., Integrated DNA Technologies, Inc., and Illumina Inc. ensure that innovative synthesis methods and sequencing technologies remain at the forefront of industry development. Firms like LanzaTech, Mammoth Biosciences, Inc., and New England Biolabs contribute through transformative process optimizations. Strategic players such as Sojitz Corporation, Synbio Technologies, Twist Bioscience Corporation, and Zymergen Inc. complete this diverse landscape of innovators who are redefining the possibilities of synthetic biology.

The report delves into recent significant developments in the Synthetic Biology Platforms Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., American Institute of Chemical Engineers, Amyris, Inc., Antheia, Inc., Arbor Biosciences, Codexis, Inc., CSIRO, DNA Script, ElevateBio, LLC, Engineering Biology Research Center, Genetic Engineering & Biotechnology, Genomatica, Inc., Genome Canada, Ginkgo Bioworks, Inc., Gniubiotics, Harvard Medical School, Illumina Inc, Integrated DNA Technologies, Inc., LanzaTech, Mammoth Biosciences, Inc., New England Biolabs, Sojitz Corporation, Synbio Technologies, Twist Bioscience Corporation, and Zymergen Inc.. Actionable Recommendations for Thriving in the Synthetic Biology Sector

Industry leaders must adapt to the rapidly changing ecosystem by embracing integrated innovation strategies and forward-thinking policies. It is essential to invest in research and development that fosters cross-disciplinary collaboration, leveraging expertise from bioinformatics, data analytics, and molecular biology to drive breakthrough discoveries. Leaders should consider expanding partnerships with academic institutions and technology firms to share knowledge and reduce time-to-market for new applications.

Furthermore, companies are encouraged to prioritize flexible manufacturing processes and scalability. Emphasizing automation and utilizing high-throughput screening technologies can streamline production workflows and enhance operational efficiency. Concurrently, ensuring compliance with evolving regulatory standards will be crucial for long-term success in this complex marketplace.

It is also advised that organizations pursue market diversification by extending their focus beyond core therapeutic applications. Enhancing engagement with emerging segments such as agricultural innovations, food safety enhancements, and environmental sustainability initiatives can open new streams of revenue. Continuous monitoring of regional market dynamics and investment in cutting-edge project pilots can serve as powerful levers to secure competitive advantage. Ultimately, actionable collaboration along with proactive adoption of emerging technologies will be the cornerstone for sustained leadership in the synthetic biology arena.

Synthesizing Conclusions and Insights for a Progressive Future

The synthetic biology sector is clearly at a pivotal junction, marked by rapid technological evolution and robust market expansion. Our analysis has shown that while the industry presents complex challenges, it also opens up vast opportunities for innovation, economic growth, and societal benefits. The convergence of advanced genetic tools, automation, and data-driven methodologies has enabled the creation of novel biological solutions that are reshaping therapeutic, agricultural, and industrial paradigms.

As leaders navigate this dynamic landscape, it is crucial to appreciate the interdependencies across segments, regions, and corporate actors. A holistic understanding of market segmentation - spanning offerings, applications, and end-user criteria - equips stakeholders with the insights needed to make informed, strategic decisions. The competitive environment, bolstered by key companies with diverse capabilities, underscores the importance of fostering continuous innovation and strategic collaboration.

In summary, a forward-looking approach that integrates technological advancements, regional strengths, and diversified market strategies will enable industry players to harness the full potential of synthetic biology. The future promises significant returns on investments made in research and technology with a proactive adaptation to global standards and trends.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. General trend towards personalized medicine and tailored healthcare solutions growing adoption
      • 5.1.1.2. Expansion of bioinformatics and computational tools aiding in synthetic pathway design
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of research and development and compatibility issues
    • 5.1.3. Opportunities
      • 5.1.3.1. Global need for effective solutions in healthcare and agriculture fueling synthetic biology
      • 5.1.3.2. Harnessing synthetic biology to create biodegradable alternatives to traditional plastics
    • 5.1.4. Challenges
      • 5.1.4.1. Challenges in combating cybersecurity threats and ensuring data integrity in synthetic biology innovations
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Offering: Evolving mRNA synthesis invigorated by the mRNA vaccine revolution
    • 5.2.2. End User: Expanding usage of the synthetic-biology-platforms across the pharmaceutical & life science industry
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Synthetic Biology Platforms Market, by Offering

  • 6.1. Introduction
  • 6.2. DNA Sequencing
  • 6.3. DNA Synthesis
  • 6.4. mRNA Synthesis

7. Synthetic Biology Platforms Market, by Application

  • 7.1. Introduction
  • 7.2. Antibody Discovery & NGS
  • 7.3. Cell & Gene Therapy
  • 7.4. Vaccine Development

8. Synthetic Biology Platforms Market, by End User

  • 8.1. Introduction
  • 8.2. Agriculture Industry
  • 8.3. Food & Beverage Industry
  • 8.4. Pharmaceutical & Life Science Industry

9. Americas Synthetic Biology Platforms Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Synthetic Biology Platforms Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Synthetic Biology Platforms Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2024
  • 12.2. FPNV Positioning Matrix, 2024
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. LVMH Recherche and Integrated Biosciences to enhance anti-aging skincare using AI and synthetic biology platforms
    • 12.3.2. Ansa Biotechnologies advances DNA synthesis with new assembly technology
    • 12.3.3. Researchers at Yale developed a generative AI platform for synthetic DNA sequences
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. American Institute of Chemical Engineers
  • 3. Amyris, Inc.
  • 4. Antheia, Inc.
  • 5. Arbor Biosciences
  • 6. Codexis, Inc.
  • 7. CSIRO
  • 8. DNA Script
  • 9. ElevateBio, LLC
  • 10. Engineering Biology Research Center
  • 11. Genetic Engineering & Biotechnology
  • 12. Genomatica, Inc.
  • 13. Genome Canada
  • 14. Ginkgo Bioworks, Inc.
  • 15. Gniubiotics
  • 16. Harvard Medical School
  • 17. Illumina Inc
  • 18. Integrated DNA Technologies, Inc.
  • 19. LanzaTech
  • 20. Mammoth Biosciences, Inc.
  • 21. New England Biolabs
  • 22. Sojitz Corporation
  • 23. Synbio Technologies
  • 24. Twist Bioscience Corporation
  • 25. Zymergen Inc.

LIST OF FIGURES

  • FIGURE 1. SYNTHETIC BIOLOGY PLATFORMS MARKET MULTI-CURRENCY
  • FIGURE 2. SYNTHETIC BIOLOGY PLATFORMS MARKET MULTI-LANGUAGE
  • FIGURE 3. SYNTHETIC BIOLOGY PLATFORMS MARKET RESEARCH PROCESS
  • FIGURE 4. SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 15. AMERICAS SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 17. UNITED STATES SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. SYNTHETIC BIOLOGY PLATFORMS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 23. SYNTHETIC BIOLOGY PLATFORMS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. SYNTHETIC BIOLOGY PLATFORMS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SYNTHETIC BIOLOGY PLATFORMS MARKET DYNAMICS
  • TABLE 7. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY DNA SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY MRNA SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY ANTIBODY DISCOVERY & NGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY CELL & GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY AGRICULTURE INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY FOOD & BEVERAGE INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY PHARMACEUTICAL & LIFE SCIENCE INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM SYNTHETIC BIOLOGY PLATFORMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. SYNTHETIC BIOLOGY PLATFORMS MARKET SHARE, BY KEY PLAYER, 2024
  • TABLE 147. SYNTHETIC BIOLOGY PLATFORMS MARKET, FPNV POSITIONING MATRIX, 2024